A House committee hearing on the Food and Drug Administration's progress toward implementing a federal law requiring it to develop a regulatory strategy for health information technology was postponed last Thursday as the government shutdown continued, according to an article on the Modern Healthcare website.
Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, was scheduled to testify before the Health Subcommittee of the House Energy and Commerce Committee on the Food and Drug Administration Safety Innovation Act. Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, was also scheduled to testify at the subcommittee hearing.
The 2012 law requires HHS, through the FDA, and in consultation with the Office of the National Coordinator of Health Information Technology and the Federal Communications Commission, to develop "a proposed strategy and recommendations on an appropriate, risk-based regulatory framework pertaining to health information technology, including mobile medical applications, that promotes innovation, protects patient safety and avoids regulatory duplication," according to the article.
Read the article.
Upward Mobility: Market Forces Drive Hospitals Higher
Georgia Hospital Bomb Hoaxes Highlight Need for Healthcare–Police Partnerships
MUSC Health Celebrates Groundbreaking for Nexton Hospital and Ambulatory Cancer Facility
Mattresses Require Strict Care to Prevent Spread of Infections
Gardner Health Services Opens Alum Rock Health Center